These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 37622317)

  • 21. Clinical Outcomes of Hospitalized Patients with SARS-CoV-2 Omicron Variant vs. Influenza A During Influenza Season 2021 to 2022: A Retrospective Observational Study.
    Atamna A; Berkov E; Drozdinsky G; Shochat T; Ben Zvi H; Eliakim-Raz N; Bishara J; Elis A
    Isr Med Assoc J; 2023 Sep; 25(9):585-589. PubMed ID: 37698307
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Trends in Disease Severity and Health Care Utilization During the Early Omicron Variant Period Compared with Previous SARS-CoV-2 High Transmission Periods - United States, December 2020-January 2022.
    Iuliano AD; Brunkard JM; Boehmer TK; Peterson E; Adjei S; Binder AM; Cobb S; Graff P; Hidalgo P; Panaggio MJ; Rainey JJ; Rao P; Soetebier K; Wacaster S; Ai C; Gupta V; Molinari NM; Ritchey MD
    MMWR Morb Mortal Wkly Rep; 2022 Jan; 71(4):146-152. PubMed ID: 35085225
    [TBL] [Abstract][Full Text] [Related]  

  • 23. No excess mortality among working-age Italians during the Omicron wave of Covid-19.
    Alicandro G; Remuzzi G; Centanni S; Gerli A; La Vecchia C
    Med Lav; 2022 Jun; 113(3):e2022030. PubMed ID: 35766642
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Reinfections with Different SARS-CoV-2 Omicron Subvariants, France.
    Nguyen NN; Houhamdi L; Delorme L; Colson P; Gautret P
    Emerg Infect Dis; 2022 Nov; 28(11):2341-2343. PubMed ID: 36150518
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparing SARS-CoV-2 with SARS-CoV and influenza pandemics.
    Petersen E; Koopmans M; Go U; Hamer DH; Petrosillo N; Castelli F; Storgaard M; Al Khalili S; Simonsen L
    Lancet Infect Dis; 2020 Sep; 20(9):e238-e244. PubMed ID: 32628905
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Changes in all-cause and cause-specific excess mortality before and after the Omicron outbreak of COVID-19 in Hong Kong.
    Chong KC; Chan PK; Hung CT; Wong CK; Xiong X; Wei Y; Zhao S; Guo Z; Wang H; Yam CH; Chow TY; Li C; Jiang X; Leung SY; Kwok KL; Yeoh EK; Li K
    J Glob Health; 2023 Apr; 13():06017. PubMed ID: 37114968
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Age distribution of influenza like illness cases during post-pandemic A(H3N2): comparison with the twelve previous seasons, in France.
    Turbelin C; Souty C; Pelat C; Hanslik T; Sarazin M; Blanchon T; Falchi A
    PLoS One; 2013; 8(6):e65919. PubMed ID: 23755294
    [TBL] [Abstract][Full Text] [Related]  

  • 28. When the COVID-19 Pandemic Surges during Influenza Season: Lessons Learnt from the Sentinel Laboratory-Based Surveillance of Influenza-Like Illness in Lombardy during the 2019-2020 Season.
    Galli C; Pellegrinelli L; Bubba L; Primache V; Anselmi G; Delbue S; Signorini L; Binda S; Cereda D; Gramegna M; Pariani E; The Ili Sentinel Physicians Group
    Viruses; 2021 Apr; 13(4):. PubMed ID: 33923819
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Estimation of Excess Deaths Associated With the COVID-19 Pandemic in the United States, March to May 2020.
    Weinberger DM; Chen J; Cohen T; Crawford FW; Mostashari F; Olson D; Pitzer VE; Reich NG; Russi M; Simonsen L; Watkins A; Viboud C
    JAMA Intern Med; 2020 Oct; 180(10):1336-1344. PubMed ID: 32609310
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Favorable outcomes of COVID-19 in vaccinated hematopoietic stem cell transplant recipients: A single-center experience.
    Tan JY; Wee LE; Tan YH; Conceicao EP; Lim FWI; Chen Y; Than H; Quek JKS; Nagarajan C; Goh YT; Hwang WYK; Phua GC; Chung SJ; Tan TT; Linn YC; Ho AYL; Tan BH
    Transpl Infect Dis; 2023 Jun; 25(3):e14024. PubMed ID: 36715661
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Excess cases of influenza-like illnesses synchronous with coronavirus disease (COVID-19) epidemic, France, March 2020.
    Boëlle PY; Souty C; Launay T; Guerrisi C; Turbelin C; Behillil S; Enouf V; Poletto C; Lina B; van der Werf S; Lévy-Bruhl D; Colizza V; Hanslik T; Blanchon T
    Euro Surveill; 2020 Apr; 25(14):. PubMed ID: 32290901
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effectiveness of BNT162b2 and CoronaVac COVID-19 vaccination against asymptomatic and symptomatic infection of SARS-CoV-2 omicron BA.2 in Hong Kong: a prospective cohort study.
    Tsang NNY; So HC; Cowling BJ; Leung GM; Ip DKM
    Lancet Infect Dis; 2023 Apr; 23(4):421-434. PubMed ID: 36521506
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparison of Influenza and Coronavirus Disease 2019-Associated Hospitalizations Among Children Younger Than 18 Years Old in the United States: FluSurv-NET (October-April 2017-2021) and COVID-NET (October 2020-September 2021).
    Delahoy MJ; Ujamaa D; Taylor CA; Cummings C; Anglin O; Holstein R; Milucky J; O'Halloran A; Patel K; Pham H; Whitaker M; Reingold A; Chai SJ; Alden NB; Kawasaki B; Meek J; Yousey-Hindes K; Anderson EJ; Openo KP; Weigel A; Teno K; Reeg L; Leegwater L; Lynfield R; McMahon M; Ropp S; Rudin D; Muse A; Spina N; Bennett NM; Popham K; Billing LM; Shiltz E; Sutton M; Thomas A; Schaffner W; Talbot HK; Crossland MT; McCaffrey K; Hall AJ; Burns E; McMorrow M; Reed C; Havers FP; Garg S
    Clin Infect Dis; 2023 Feb; 76(3):e450-e459. PubMed ID: 35594564
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Considering Interim Interventions to Control COVID-19 Associated Morbidity and Mortality-Perspectives.
    Arokiaraj MC
    Front Public Health; 2020; 8():444. PubMed ID: 33072682
    [No Abstract]   [Full Text] [Related]  

  • 35. Vaccine effectiveness and duration of protection of COVID-19 mRNA vaccines against Delta and Omicron BA.1 symptomatic and severe COVID-19 outcomes in adults aged 50 years and over in France.
    Tamandjou Tchuem CR; Auvigne V; Vaux S; Montagnat C; Paireau J; Monnier Besnard S; Gabet A; Benhajkassen N; Le Strat Y; Parent Du Chatelet I; Levy-Bruhl D
    Vaccine; 2023 Mar; 41(13):2280-2288. PubMed ID: 36870880
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Estimated Number of COVID-19 Infections, Hospitalizations, and Deaths Prevented Among Vaccinated Persons in the US, December 2020 to September 2021.
    Steele MK; Couture A; Reed C; Iuliano D; Whitaker M; Fast H; Hall AJ; MacNeil A; Cadwell B; Marks KJ; Silk BJ
    JAMA Netw Open; 2022 Jul; 5(7):e2220385. PubMed ID: 35793085
    [TBL] [Abstract][Full Text] [Related]  

  • 37. SARS-CoV-2 and influenza virus coinfection among patients with severe acute respiratory infection during the first wave of COVID-19 pandemic in Bangladesh: a hospital-based descriptive study.
    Akhtar Z; Islam MA; Aleem MA; Mah-E-Muneer S; Ahmmed MK; Ghosh PK; Rahman M; Rahman MZ; Sumiya MK; Rahman MM; Shirin T; Alamgir ASM; Banu S; Rahman M; Chowdhury F
    BMJ Open; 2021 Nov; 11(11):e053768. PubMed ID: 34845073
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Analyzing and Modeling the Spread of SARS-CoV-2 Omicron Lineages BA.1 and BA.2, France, September 2021-February 2022.
    Sofonea MT; Roquebert B; Foulongne V; Morquin D; Verdurme L; Trombert-Paolantoni S; Roussel M; Bonetti JC; Zerah J; Haim-Boukobza S; Alizon S
    Emerg Infect Dis; 2022 Jul; 28(7):1355-1365. PubMed ID: 35642476
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Mortality associated with influenza and respiratory syncytial virus in the United States.
    Thompson WW; Shay DK; Weintraub E; Brammer L; Cox N; Anderson LJ; Fukuda K
    JAMA; 2003 Jan; 289(2):179-86. PubMed ID: 12517228
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Vaccine effectiveness against SARS-CoV-2 reinfection during periods of Alpha, Delta, or Omicron dominance: A Danish nationwide study.
    Nielsen KF; Moustsen-Helms IR; Schelde AB; Gram MA; Emborg HD; Nielsen J; Hansen CH; Andersen MA; Meaidi M; Wohlfahrt J; Valentiner-Branth P
    PLoS Med; 2022 Nov; 19(11):e1004037. PubMed ID: 36413551
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.